Novartis Issues Recall In Six Caribbean Nations

News Americas, NEW YORK, NY, Tues. Feb. 5, 2013: Several cough syrups are being voluntarily recalled by Novartis Pharma Logistics, Inc. in six Caribbean nations.

The recall involves certain lots of Triaminic® Syrups, Theraflu Warming Relief® Syrups, Jack & Jill® brand pediatric syrups and Buckley’s® Complete Liquids.
A company statement late Tuesday said consumers who may have the product (s) being recalled are asked to return the affected products and receive a full refund. The products being recalled were produced at a Novartis Consumer Health manufacturing facility in the United States prior to the voluntary suspension of operations in December 2011, and at a third-party manufacturing site in Canada using the same bottle and cap components.

The recall is for Trinidad & Tobago, The Bahamas, Jamaica, Aruba, Barbados and Curacao.

The drugs are being recalled, said Novartis, “because the child-resistant feature of the bottle cap may not function properly, enabling the cap to be removed with the tamper-evident seal still in place.”

Novartis Pharma Logistics advises consumers who believe they have product included in this recall to discontinue use and return the recalled product to the store or pharmacy where it was purchased for a full refund. Only recalled product in the original bottle will be eligible for a refund.

Consumers may contact the Novartis Consumer Relationship Center at 877-769-8420 (available Monday-Saturday 8 a.m. to 6 p.m. Eastern Time) for more detailed information about the recall, including which products are impacted, and for information on how to return the affected products and receive a full refund.
Please note the products being recalled for Trinidad and Tobago

For Barbados:

For Jamaica:

For the Bahamas:

For Aruba:

For Curacao: